FR2962550B1 - Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode - Google Patents

Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode

Info

Publication number
FR2962550B1
FR2962550B1 FR1055490A FR1055490A FR2962550B1 FR 2962550 B1 FR2962550 B1 FR 2962550B1 FR 1055490 A FR1055490 A FR 1055490A FR 1055490 A FR1055490 A FR 1055490A FR 2962550 B1 FR2962550 B1 FR 2962550B1
Authority
FR
France
Prior art keywords
chemical submission
submission
implementation
pharmaceutical composition
coloring agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1055490A
Other languages
English (en)
French (fr)
Other versions
FR2962550A1 (fr
Inventor
Catherine Herry
Pauline Contamin
Emmanuel Dupau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1055490A priority Critical patent/FR2962550B1/fr
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Priority to KR1020187019307A priority patent/KR101957657B1/ko
Priority to US13/808,807 priority patent/US20130098286A1/en
Priority to ES11743099.1T priority patent/ES2609831T3/es
Priority to PCT/FR2011/051600 priority patent/WO2012010765A1/fr
Priority to AU2011281482A priority patent/AU2011281482B2/en
Priority to KR1020137003073A priority patent/KR20130091321A/ko
Priority to JP2013517480A priority patent/JP5916723B2/ja
Priority to MX2012015103A priority patent/MX344783B/es
Priority to CA2802402A priority patent/CA2802402A1/fr
Priority to EP11743099.1A priority patent/EP2591350B1/fr
Priority to CN2011800334204A priority patent/CN103119435A/zh
Publication of FR2962550A1 publication Critical patent/FR2962550A1/fr
Priority to IL223886A priority patent/IL223886B/en
Priority to ZA2013/00099A priority patent/ZA201300099B/en
Application granted granted Critical
Publication of FR2962550B1 publication Critical patent/FR2962550B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1055490A 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode Active FR2962550B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR1055490A FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
EP11743099.1A EP2591350B1 (fr) 2010-07-06 2011-07-05 Méthode et agent pour la détection de drogues dans les boisson
ES11743099.1T ES2609831T3 (es) 2010-07-06 2011-07-05 Método y agente para la detección de drogas en bebidas
PCT/FR2011/051600 WO2012010765A1 (fr) 2010-07-06 2011-07-05 Methode et agent pour la detection de drogues dans les boisson
AU2011281482A AU2011281482B2 (en) 2010-07-06 2011-07-05 Method and agent for detecting drugs in beverages
KR1020137003073A KR20130091321A (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분
JP2013517480A JP5916723B2 (ja) 2010-07-06 2011-07-05 飲料中の薬物を検出するための方法および薬剤
MX2012015103A MX344783B (es) 2010-07-06 2011-07-05 Metodo y agente para detectar farmacos en bebidas.
KR1020187019307A KR101957657B1 (ko) 2010-07-06 2011-07-05 음료 내의 약물을 검출하기 위한 방법 및 성분
US13/808,807 US20130098286A1 (en) 2010-07-06 2011-07-05 Method and agent for detecting drugs in beverages
CN2011800334204A CN103119435A (zh) 2010-07-06 2011-07-05 用于检测饮料中的药物的方法和试剂
CA2802402A CA2802402A1 (fr) 2010-07-06 2011-07-05 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
IL223886A IL223886B (en) 2010-07-06 2012-12-25 A method to combat the clandestine administration of chemicals, the use of a dye to combat the clandestine administration of chemicals and a pharmaceutical preparation that enables the application of the method
ZA2013/00099A ZA201300099B (en) 2010-07-06 2013-01-04 Method and agent for detecting drugs in beverages

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1055490A FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode

Publications (2)

Publication Number Publication Date
FR2962550A1 FR2962550A1 (fr) 2012-01-13
FR2962550B1 true FR2962550B1 (fr) 2013-06-14

Family

ID=43587415

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1055490A Active FR2962550B1 (fr) 2010-07-06 2010-07-06 Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode

Country Status (13)

Country Link
US (1) US20130098286A1 (enExample)
EP (1) EP2591350B1 (enExample)
JP (1) JP5916723B2 (enExample)
KR (2) KR20130091321A (enExample)
CN (1) CN103119435A (enExample)
AU (1) AU2011281482B2 (enExample)
CA (1) CA2802402A1 (enExample)
ES (1) ES2609831T3 (enExample)
FR (1) FR2962550B1 (enExample)
IL (1) IL223886B (enExample)
MX (1) MX344783B (enExample)
WO (1) WO2012010765A1 (enExample)
ZA (1) ZA201300099B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104237224A (zh) * 2014-10-14 2014-12-24 厦门奥亚仪器有限公司 苯二氮卓的快速检测方法及其操作器皿组合
US20220202742A1 (en) * 2019-05-07 2022-06-30 Clexio Biosciences Ltd. Dosage forms for preventing drug-facilitated assault
US20220175719A1 (en) * 2020-10-24 2022-06-09 Mason Cave Dissolvable thc beverage tablet production method
US20220241238A1 (en) * 2020-10-24 2022-08-04 Michael Roth Method for forming a beverage with a dissolvable thc tablet
CN115112582B (zh) * 2022-05-19 2024-08-09 西南科技大学 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法
CN117654708A (zh) * 2023-10-16 2024-03-08 杭州德望纳米科技有限公司 一种基于球磨实验改变蛇纹石粒度分级方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157662A (en) * 1966-08-08 1969-07-09 Codex S A Improvements in or relating to Pharmaceutical Compositions
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
US6617123B1 (en) * 2000-06-29 2003-09-09 Jack V. Smith Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
ITMI20011446A1 (it) * 2001-07-06 2003-01-06 Altergon Sa Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita
US20030044989A1 (en) * 2001-09-04 2003-03-06 Guerra Francisco Javier Apparatus and method for testing a beverage for a clandestine illicit substance
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
FR2829932B1 (fr) * 2001-09-21 2006-11-24 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu
FR2831820B1 (fr) 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US20080102482A1 (en) 2003-12-19 2008-05-01 Stanley Irwin Grossman Apparatus for Detecting Drugs in a Beverage
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
JP2009256295A (ja) * 2008-04-11 2009-11-05 Kosumedei Seiyaku Kk 化粧用粘着シート
JP5059678B2 (ja) * 2008-04-18 2012-10-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 着色固形製剤およびその製造方法
FR2962331B1 (fr) * 2010-07-06 2020-04-24 Ethypharm Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre

Also Published As

Publication number Publication date
WO2012010765A1 (fr) 2012-01-26
KR20130091321A (ko) 2013-08-16
CN103119435A (zh) 2013-05-22
AU2011281482A1 (en) 2013-01-17
KR101957657B1 (ko) 2019-03-12
US20130098286A1 (en) 2013-04-25
JP5916723B2 (ja) 2016-05-11
FR2962550A1 (fr) 2012-01-13
ES2609831T3 (es) 2017-04-24
CA2802402A1 (fr) 2012-01-26
ZA201300099B (en) 2014-03-26
EP2591350B1 (fr) 2016-10-26
KR20180080374A (ko) 2018-07-11
AU2011281482B2 (en) 2015-10-01
EP2591350A1 (fr) 2013-05-15
JP2013530206A (ja) 2013-07-25
IL223886B (en) 2018-03-29
MX344783B (es) 2017-01-06
MX2012015103A (es) 2013-05-28

Similar Documents

Publication Publication Date Title
FR2962550B1 (fr) Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode
EP2646044A4 (en) PROCESS FOR INCREASING THE INTRA-CELLULAR ACTIVITY OF HSP70
EP2536397A4 (en) Solid pharmaceutical composition with enhancers and methods of preparing thereof
EP3453065A4 (en) REACTOR WITH EXTENDED ARCHITECTURE FOR THE ELECTROCHEMICAL REACTION OF CO2, CO AND OTHER CHEMICAL COMPOUNDS
EP2547999A4 (en) Clarifying reagent for a biological material and use thereof
EP2018365A4 (en) NEW MATERIALS FOR COATING LITHOGRAPHIC PLATES, LITHOGRAPHIC PLATES AND COATINGS THEREOF, METHOD OF PRODUCTION AND USE
EP3359666C0 (en) EARLY POST-TRANSFECTION ISOLATION OF CELLS TO PREPARE BIOLOGICAL PRODUCTS
DE102016209214A8 (de) Heißsiegelbare und peelfähige Polyesterfolie, Verfahren zu ihrer Herstellung und ihre Verwendung
EP2622133A4 (en) CELLULOSE-REINFORCED PRODUCTS WITH HIGH MINERAL QUANTITY AND METHOD FOR THE PRODUCTION THEREOF
EP2558072A4 (en) PRODRUG COMPOSITIONS, PRODRUG NANOPARTICLES AND METHOD OF APPLICATION THEREOF
EP3209725A4 (en) Curable, resealable, swellable, reactive sealant composition for zonal isolation and well integrity
EP2644668A4 (en) UV-CURABLE COATING COMPOSITION WITH SELF-HORIZONTAL PROPERTIES, COATING FILM AND METHOD FOR PRODUCING THE COATING FILM
HUE037747T2 (hu) Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
FI20085509A0 (fi) Reaktioastia ja menetelmä sen käsittelemiseksi
FR2949065B1 (fr) Complexe eclaircissant la peau, utilisation dudit complexe, composition cosmetique ou pharmaceutique comprenant ledit complexe et procede pour son application
HUE042948T2 (hu) Lezárható tárolóedény és eljárás lezárható tárolóedény, valamint lezárt tárolóedény elõállítására
BRPI0907916A2 (pt) Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
EP2606139A4 (en) BIO-CATALYSTS AND METHOD FOR SYNTHESIS OF (1R, 2R) -2- (3,4-DIMETHOXYPHENETHOXY-) CYCLOHEXANAMINE
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
EP2653165A4 (en) HOPE OXYDATION PRODUCT, MANUFACTURING METHOD AND USE THEREOF
GB2453982B (en) Chemical process for the preparation of Medetomidine
HUE060079T2 (hu) Egyenáramú és ellenáramú, gyantatartalmú lúgzóoldatos módszer arany kilúgozó eljárások esetén
EP2887804A4 (en) METHODS OF SYNTHESIS OF CYCLOALKANYL (B) INDOLES, CYCLOALKANYL (B) BENZOFURANES, CYCLOALKANYL (B) BENZOTHIOPHENES, COMPOUNDS AND METHOD OF USE
DK2281822T3 (da) Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse

Legal Events

Date Code Title Description
GC Lien (pledge) constituted

Effective date: 20140519

PLFP Fee payment

Year of fee payment: 6

GC Lien (pledge) constituted

Effective date: 20160120

RG Lien (pledge) cancelled

Effective date: 20160226

PLFP Fee payment

Year of fee payment: 7

RG Lien (pledge) cancelled

Effective date: 20170418

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16